Featured Posts
-
-
3 Exciting Uses of Data for the Future of Vaccine Development
/ By Tim / Featured on App, R&D / 0 comments
-
Ineffective – HVTN 505 HIV Vaccine Trial Discontinued
/ By Tim / Featured on App, Prophylactic Vaccines, R&D / 2 comments
Recent Posts
-
Lyme Disease vaccine shows promise in Phase I/II trial
/ By Tim / Featured on App, Prophylactic Vaccines, R&D / 0 comments
-
-
Media surveillance system analyses public concerns about vaccines
/ By Tim / Featured on App / 1 comment
-
India announces development of $1 rotavirus vaccine
/ By Tim / Emerging Markets, Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 1 comment
-
Bill and Melinda Gates Foundation – Investing in global health – Kim Bush
/ By Tim / Featured Videos, Featured on App / 0 comments
-
Anti-Cocaine vaccine successfully tested in primates
/ By Tim / Featured on App, R&D, Therapeutic Vaccines / 0 comments
-
New vaccines needed for pathogens infecting animals and humans: One Health – Dr. Thomas P. Monath
/ By Tim / Featured Videos, Featured on App / 1 comment
-
Providing global access to vaccines is a team effort – George Adams
/ By Tim / Featured Videos, Featured on App / 0 comments
-
Disease prevention in low and middle income countries – Lois Privor Dumm
/ By Tim / Featured Videos, Featured on App / 0 comments
-
GSK analyses discussion forums for parental concerns about vaccines
/ By Tim / Featured on App, Partnering and Corporate strategy / 0 comments
